Ionis Pharmaceuticals (IONS) EBT Margin Growth (3y) (2012 - 2026)

Ionis Pharmaceuticals (IONS) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ionis Pharmaceuticals 9.21 Bn 7.29 Bn 243.11 Mn 4,902.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,902.00
Dec 31, 2025 -8,291.00
Sep 30, 2025 -5,269.00
Jun 30, 2025 625,344.00
Mar 31, 2025 -6,641.00
Dec 31, 2024 -10,545.00
Sep 30, 2024 -4,474.00
Jun 30, 2024 3,466.00
Mar 31, 2024 -3,903.00
Dec 31, 2023 -19,540.00
Sep 30, 2023 -7,793.00
Jun 30, 2023 23,179.00
Mar 31, 2023 -4,682.00
Dec 31, 2022 20,641.00
Sep 30, 2022 -4,330.00
Jun 30, 2022 20,542.00
Mar 31, 2022 -12,643.00
Dec 31, 2021 -360.00
Sep 30, 2021 13,619.00
Jun 30, 2021 -1,631.00